Morpheus® III

SHARE

Mail Icon Google+ Facebook Twitter

Morpheus® III

Cure your screening problems with the drug-like additives in Morpheus III.

Exclusively from Molecular Dimensions, the new Morpheus® III screen uniquely contains a range of small, drug-like compounds to aid protein stabilisation and crystallisation.


Read here about how Morpheus III and it's rational screening methodology can help your screening efforts  by expanding the range of chemical space you screen.

References
G
orrec, F. The Morpheus II protein crystallization screen. Acta Crystallographica section F Structural Biology Communications 71: 831-837 (2015).
Gorrec, F. The current approach to initial crystallization screening of proteins is under-sampled. Journal of Applied Crystallography 46: 795-7 (2013).
Gorrec, F. The MORPHEUS protein crystallization screen. Journal Applied Crystallography 42: 1035-42.

The Morpheus® III screen was developed at the MRC-LMB, Cambridge, UK and exclusively licensed to Molecular Dimensions by LifeARC.

  • Description

    Morpheus Complete

  • Price

  • Description

    Hippocrates

  • Price

Page 1 of 1   [1]

Europe & the
rest of the world

Unit 6, Goodwin Business Park
Willie Snaith Road,
Newmarket,
Suffolk, CB8 7SQ, UK

Phone +44 (0)1638 561051
Fax +44 (0)1638 660674
Technical: enquiries@moleculardimensions.com
Sales: orders@moleculardimensions.com

Privacy Policy

USA, Canada, Mexico,
Central & South America

434 West Dussel Drive
Maumee
OH 43537
USA

Phone +1 877 479 4339 / +1 407 886 6901
Fax +1 321 972-8896
Technical: enquiries@moleculardimensions.com
Sales: usorders@moleculardimensions.com

Follow us

FB Like Icon Twitter Icon

LinkedIn Icon

YouTube Icon

Pinterest Icon